Voltage-gated and other calcium-permeable ion channels (VGCC/Ca-channels)

Voltage-gated and other calcium-permeable ion channels represent a broad class of transmembrane proteins that facilitate the selective entry of calcium ions (Ca2+) into cells in response to electrical or chemical stimuli. This category encompasses voltage-gated calcium channels (VGCCs), which are classified into L-type, P/Q-type, N-type, R-type, and T-type based on their physiological and pharmacological properties, as well as other calcium-permeable channels like Transient Receptor Potential (TRP) channels and NMDA receptors (UniProt, 2024). These channels are essential for coupling membrane depolarization to intracellular processes, including the contraction of cardiac and smooth muscle, the release of neurotransmitters in the central nervous system, and the activation of calcium-dependent signaling pathways that regulate gene expression. Dysregulation of calcium channel activity is a primary driver in various pathologies, such as hypertension, cardiac arrhythmias, chronic neuropathic pain, and absence seizures (PubMed, PMID: 25655837). Pharmacological intervention often involves calcium channel blockers (CCBs) like dihydropyridines for cardiovascular management or gabapentinoids that target auxiliary subunits to treat neurological conditions. Because this entry describes a large family of proteins rather than a single molecular entity, it is considered a high-level classification in therapeutic databases (IUPHAR/BPS Guide to PHARMACOLOGY).

Other names

Calcium channelsCa2+ channelsVoltage-dependent calcium channelsVDCCLigand-gated calcium-permeable channelsCalcium-selective channels

Drugs typically act as pore blockers that physically obstruct the ion-conducting pathway, allosteric modulators that stabilize the channel in an inactive or closed state, or ligands that bind to auxiliary subunits (such as the alpha-2-delta subunit) to reduce channel trafficking and calcium current (StatPearls, 2023; IUPHAR/BPS Guide to PHARMACOLOGY).